{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:17:07Z","timestamp":1786378627973,"version":"build-2736575974"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00171","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T17:15:19Z","timestamp":1553706919000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy"],"prefix":"10.3389","volume":"10","author":[{"given":"Xiangbing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqiong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Trooskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue A.","family":"Shapses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary hyperparathyroidism","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1210\/jc.85.3.1054","article-title":"Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications","volume":"85","author":"Rao","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"981581","DOI":"10.1155\/2014\/981581","article-title":"Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions","volume":"2014","author":"Youselzadeh","year":"2014","journal-title":"Int J Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4158\/EP161604.RA","article-title":"Vitamin D binding protein and 25-hydroxyvitamin D levels: emerging clinical applications","volume":"23","author":"Jassil","year":"2017","journal-title":"Endocr Pract"},{"key":"B6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.4158\/EP12371.OR","article-title":"Vitamin D binding protein levels in female patients with primary hyperparathyroidism","volume":"19","author":"Wang","year":"2013","journal-title":"Endocr Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12020-016-0974-x","article-title":"Vitamin D status in primary hyperparathyroidism: effect of genetic background","volume":"55","author":"Battista","year":"2017","journal-title":"Endocrine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4158\/EP161434.OR","article-title":"Free and bioavailable 25-hydroxyvitamin D Levels in patients with primary hyperparathyroidism","volume":"23","author":"Wang","year":"2017","journal-title":"Endocr Pract"},{"key":"B9","doi-asserted-by":"publisher","first-page":"628687","DOI":"10.1155\/2018\/628687","article-title":"Comparison of initial clinical presentations between primary hyperparathyroidism patients from new brunswick and changsha","volume":"2018","author":"Meng","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2265.2007.02873.x","article-title":"Age-, gender-, and weight-related effects on concentrations of 25-hydroxyvitamin D are not mediated by vitamin D binding protein","volume":"67","author":"Bolland","year":"2007","journal-title":"Clin Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The american association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1210\/jcem-63-4-954","article-title":"Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein","volume":"63","author":"Bikle","year":"1986","journal-title":"J Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1210\/jc.2016-1104","article-title":"Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on racial-genotypic associations","volume":"101","author":"Nielson","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/s13104\u2013018-3725\u20137","article-title":"Vitamin D binding protein is not affected by high-dose vitamin D supplementation: a post hoc analysis of a randomised, placebo-controlled study","volume":"11","author":"Bj\u00f6rkhem-Bergman","year":"2018","journal-title":"BMC Res Notes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00198-016-3735-z","article-title":"Three doses of vitamin D (3DD) on bone mineral density (BMD) and geometry in older women during modest weight loss","volume":"28","author":"Pop","year":"2017","journal-title":"Osteoporosis Int"},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-11-0523","article-title":"Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?","volume":"166","author":"Witteveen","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1210\/JC.2015-2066","article-title":"Free 25(OH)D and the vitamin D paradox in african americans","volume":"100","author":"Aloia","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4158\/EP15623.OR","article-title":"Vitamin D binding protein in healthy pre- and postmenopausal women: relationship with estradiol concentrations","volume":"21","author":"Pop","year":"2015","journal-title":"Endocr Pract"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1210\/jc.2018-00336","article-title":"Hormonal contraceptive use is associated with higher total but unaltered free 25-hydroxyvitamin D serum concentrations.","volume":"103","author":"Pilz","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1210\/jc.2018\u201300295","article-title":"Determination of free 25(OH)D concentrations and their relationships to total 25(OH)D in multiple clinical populations","volume":"103","author":"Schwartz","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/nep.12638","article-title":"Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome","volume":"21","author":"Aggarwal","year":"2016","journal-title":"Nephrology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1111\/liv.12819","article-title":"Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction","volume":"35","author":"Lai","year":"2015","journal-title":"Liver Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/CIRCRESAHA.118.313558","article-title":"Serum bioavailable and free 25-hydroxyvitamin D levels, but not its total level, are associated with the risk of mortality in patients with coronary artery disease","volume":"123","author":"Yu","year":"2018","journal-title":"Circ Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/jamainternmed.2015.7148","article-title":"Monthly high-dose vitamin d treatment for the prevention of functional decline: a randomized clinical trial","volume":"176","author":"Bischoff-Ferrari","year":"2016","journal-title":"JAMA Intern Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jsbmb.2017.01.007","article-title":"Vitamin D metabolites in captivity?","volume":"173","author":"Bikle","year":"2017","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1210\/jc.2013-3874","article-title":"A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations","volume":"99","author":"Schwartz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"561214","DOI":"10.1155\/2014\/561214","article-title":"Vitamin d binding protein and bone health","volume":"2014","author":"Bhan","year":"2014","journal-title":"Int J Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"E405","DOI":"10.1152\/ajpendo.2001.280.3.E405","article-title":"Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor","volume":"280","author":"Mitnick","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00171\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T17:15:21Z","timestamp":1553706921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00171\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":30,"alternative-id":["10.3389\/fendo.2019.00171"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00171","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"article-number":"171"}}